ABOUT US

CAPITAL PARTNER

Validating the vision. Propelling growth. 

Nexstone Immunology is a Blackstone Life Sciences portfolio company with access to significant capital resources to fully fund its drug development initiatives and build the capabilities that underlie its focus on delivery of healthcare value. Operating independently under the Blackstone umbrella, Nexstone Immunology's unique business model maximizes value creation of individual drug assets and empowers the operational agility and clinical execution critical to sustainable competitive success.

Nexstone-Immunology-Capital-Partner.jpg
Nexstone Immunology's unique business model maximizes value creation of individual drug assets and empowers the operational agility and clinical execution critical to sustainable competitive success.

Backed by a significant financial investment from Blackstone, Nexstone Immunology is well-resourced to advance its lead drug candidate through near and long-term milestones; to enable future pipeline growth through the acquisition of innovative drug candidates; and to expand in-house staff and capabilities to support its strategic and operational execution.